Healthcare Industry News
Healthcare Industry news continually updated from thousands of sources around the net.
Trending on the Topix Network
World markets turned lower on Tuesday amid concerns about instability in Ukraine, the value of technology stocks and an economic slowdown in China.
1 spot in the Tampa Bay Times' Top Workplaces list for 2014. It is the third time in five years for ASI to earn the a... )--The recently discovered fracture at the Wanapum Dam's spillway structure does not currently impact bond ratings for the project's owner, the Public Utility District No.
Major U.S. stock indexes are turning higher in the late afternoon as the market shuffles between gains and losses.
St. Patrick Hospital in Missoula says it plans to add obstetrics, newborn and pediatric services as early as next year.
Beazer Homes, Ryland Group and other homebuilder stocks fell after a survey showed that the industry's confidence in the housing market remains low.
Scientists using a remote-controlled robot submersible have discovered a new species of poisonous sponge in the deep waters off San Diego.
But the Dow Jones Industrial Average, S&P 500 and the Nasdaq were all in slightly negative territory by 10:30a.m. ET.
Once you're logged in, at the top of each article, video or slideshow you will see a list of your Facebook friends who recently visited Choose to share stories you'e read with your friends or turn sharing OFF to keep your reading experience anonymous .
This Oct. 16 2012 photo shows Johnson and Johnson products, including Band Aid brand adhesive bandages, arranged for a photo in St. Petersburg, Fla.
Former Vice President Dick Cheney plans to visit Grand Rapids next week with his cardiologist to discuss Cheney's history of heart problems.
A 17-year-old jogger was taken by helicopter to Brigham and Women's Hospital in Boston for treatment after being struck by a minivan shortly before 8 a.m. today.
Merck & Co said the U.S. Food and Drug Administration on Monday approved its grass pollen allergy drug Grastek, becoming the second such immunotherapy treatment to be given the go-ahead in recent weeks.
The firm currently has a $54.00 target price on the stock, up from their previous target price of $45.00.
Whistle-blower. Greg Thorpe, a former sales representative for GlaxoSmithKline, sits at a desk in Florida with papers from the case in which he alleged the company encouraged doctors to prescribe antidepressants to children when the FDA had not approved the drugs for pediatric use.
Authorities say child abuse may be to blame for critical injuries to two infants taken to a hospital in Flint.
Now scientists are starting to use sophisticated DNA sequencing technology to determine if these "exceptional responders" carry gene variations that can lead to new treatment approaches, better targeted therapies or even the re- emergence of experimental drugs once deemed failures.